Brainsway Ltd.

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: IL0011007189

ILS

43.94

40.87 (1331.27%)

Jun 25

TAE

View all stocks in this country

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Brainsway Ltd.

Why is Brainsway Ltd. ?

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 0%

Poor long term growth as Net Sales has grown by an annual rate of 18.12% and Operating profit at 36.76% over the last 5 years
The company is Net-Debt Free

With ROE of 12.12%, it has a Very Expensive valuation with a 7.05 Price to Book Value

Over the past year, while the stock has generated a return of 111.47%, its profits have risen by 101.2% ; the PEG ratio of the company is 0.6

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Brainsway Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Brainsway Ltd.

-100.0%

17.68

43.56%

Israel TA-100

39.36%

2.05

19.19%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

18.12%

EBIT Growth (5y)

36.76%

EBIT to Interest (avg)

-8.69

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.11

Sales to Capital Employed (avg)

0.76

Tax Ratio

11.78%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.00%

ROCE (avg)

ROE (avg)

1.21%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

7.05

EV to EBIT

80.18

EV to EBITDA

62.42

EV to Capital Employed

26.46

EV to Sales

8.07

PEG Ratio

0.62

Dividend Yield

ROCE (Latest)

32.99%

ROE (Latest)

12.12%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Sideways

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend